[Effectiveness of GLP-1 receptor agonists in managing patients with type 2 diabetes].

OBJECTIVE: To evaluate the effectiveness of GLP-1 receptor agonists (GLP-1 RAs) in patients with type 2 diabetes mellitus and to describe their clinical characteristics. DESIGN: Retrospective cohort study based on electronic health records. SITE: Health centres of the Primary and Community Care Management (GAPiC) Camp de Tarragona. PARTICIPANTS: Patients aged ≥18 years with a diagnosis of type 2 diabetes mellitus on treatment with an GLP-1 RA. MAIN MEASUREMENTS: Demographic variables, glycosylated haemoglobin (HbA1c) and weight/BMI were collected to assess effectiveness; and clinical variables were recorded to assess safety. RESULTS: A total of 1227 patients (50.2% male) were included. A mean average HbA1c% reduction of 0.50% in HbA1c (p<0.001), weight reduction of 3.08kg weight (p<0.001) and BMI reduction of 0.99kg/m (p<0,001) were observed after 472 days of average treatment. CONCLUSIONS: GLP-1 RAs are effective in glycemic control and weight reduction in clinical practice. The results are consistent with international studies, although somewhat lower than pivotal trials.